ChromaDex investigates "next generation resveratrol"
This article was originally published in The Tan Sheet
Executive Summary
The phytochemical developer teams with investigators at the University of Mississippi Medical Center in Jackson to study the impact of pTeroPure pterostilbene on cardiovascular health, glucose levels, anti-aging, cognitive function and metabolic disorders. Irvine, Calif.-based ChromaDex touts the ingredient in a Sept. 7 release as chemically related to resveratrol, but with "significantly higher activity." Researchers will measure the ingredient's impact on participants' cholesterol, blood pressure and inflammatory markers in urine
You may also be interested in...
SupplySide West In Brief
Stevia pioneer to re-launch Symfre
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.